Sustained complete response of advanced hepatocellular carcinoma with metronomic capecitabine: a report of three cases

Sustained complete response of advanced hepatocellular carcinoma with metronomic capecitabine: a report of three cases

Abstract Background Hepatocellular carcinoma (HCC) is one of the most frequent causes of cancer-related death. Sorafenib, a multitarget angiogenesis inhibitor, is an approved frontline treatment for advanced HCC in Western countries, although a complete response (CR) to treatment is infrequently rep...

Full description

Bibliographic Details
Main Authors: Giovanni Brandi, Michela Venturi, Stefania De Lorenzo, Francesca Garuti, Giorgio Frega, Andrea Palloni, Ingrid Garajovà, Francesca Abbati, Gioconda Saccoccio, Rita Golfieri, Maria Abbondanza Pantaleo, Maria Aurelia Barbera
Format: Article
Language:English
Published: Wiley 2018-06-01
Series:Cancer Communications
Subjects:
Hepatocellular carcinoma
Capecitabine
Metronomic capecitabine
Complete response
Sorafenib
Online Access:http://link.springer.com/article/10.1186/s40880-018-0312-1

Internet

http://link.springer.com/article/10.1186/s40880-018-0312-1

Similar Items